SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Teresa Mortera‐Blanco(Karolinska University Hospital), Eva Hellström‐Lindberg(Karolinska University Hospital)
Cited by 74
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
A predictive model for the clinical response to low dose ara‐<i>C</i>: a study of 102 patients with myelodysplastic syndromes or acute leukaemia
|British Journal of Haematology|1992|79